Absorption and pharmacokinetics of green tea catechins in beagles

British Journal of Nutrition

Volumn 100, Issue 3, 2008, Pages 496-502

  Mata Bilbao, Maria de Lourdes ^a   Andrés Lacueva, Cristina ^a   Roura, Elena ^a   Jáuregui, Olga ^a   Escribano, Elvira ^a   Torre, Celina ^b   Lamuela Raventós, Rosa M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Affinity Petcare   (Spain)

Author keywords

Dogs; Extract; Flavanols; Metabolites; Pharmacokinetic; Plasma; Urine

Indexed keywords

CATECHIN; DRUG METABOLITE; EPICATECHIN GALLATE; EPICATECHIN GLUCURONIDE; EPICATECHIN SULFATE; EPIGALLOCATECHIN GALLATE; EPIGALLOCATECHIN GLUCURONIDE; GREEN TEA EXTRACT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG EXCRETION; DRUG METABOLISM; DRUG TRANSFORMATION; DRUG URINE LEVEL; ENTEROHEPATIC CIRCULATION; FEMALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; CATECHIN; DOGS; FEMALE; GLUCURONIDES; INTESTINAL ABSORPTION; MODELS, ANIMAL; SULFURIC ACID ESTERS; TEA; TIME FACTORS;

CANIS FAMILIARIS;

EID: 49649119079     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507898692     Document Type: Article

References (44)

1. Zaveri NT (2006) Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications. Life Sci 78, 2073-2080.
2. Cooper R, Moire DJ & Moire DM (2005) Medicinal benefits of green tea, I: review of noncancer health benefits. J Altern Complement Med 11 521-528.
3. Frei B & Higdon JV (2003) Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J Nutr 133, 3275S-3284S.
4. Bettuzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G & Corti A (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Res 66, 1234-1240.
5. Graham HN (1992) Green tea composition, consumption, and polyphenol chemistry. Prev Med 21, 334-350.
6. Choi JY, Park CS, Kim DJ, Cho MI-1, Jin BK, Pie JE & Chung WG (2002) Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin-3-gatiate. Neurotoxicology 23, 367-374.
7. Ramassamy C (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets. Eur J Pharmacol 545, 51-64.
8. Obregon DF, Rezai-Zadeh K, Bai Y, et al. (2006) ADAM10 activation is required for green tea-EGCG-induced alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 281, 16419-16427.
9. Choi YB, Kim YL, Lee KS, Kim BS & Kim DJ (2004) Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats. Brain Res 1019, 47-54.
10. Koh SH, Lee SM, Kim HY, et al. (2006) The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neuro Lett 395, 103-107.
11. Lin JK & Lin-Shiau SY (2006) Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res 50, 211-217.
12. Anderson RA & Polansky MM (2002) Tea enhances insulin activity. J Agric Food Chem 50, 7182-7186.
13. Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T & Kimura L (2004) Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. Pharmacology 4, 18.
14. Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M & Mukhtar H (2007) Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res 13, 1611-1619.
15. Kumar N, Shibata D, Helm. J, Coppola D & Malafa M (2007) Green tea polyphenols in the prevention of colon cancer. Front Biosci 12 2309-2315.
16. Clark J & You M (2006) Chemoprevention of lung cancer by tea. Mol Nutr Food Res 50, 144-151.
17. Guo Q, Zhao B, Shen S, Hoou J, Hu J & Yin W (1999) ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim Biophys Acta 1427, 13-23.
18. Ahmed S, Pakozdi A & Koch AE (2006) Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 54 2393-2401.
19. Tedeshi E, Suzuki H & Megazzi M (2002) Antiinflammatory, action of EGCG, the main component of green tea, through STAT-1 inhibition. Ann N Y Acad Sci 973, 435-437.
20. Unno T, Sagesaka YM & Kakuda T (2005) Analysis of tea catechins in human plasma by high-performance liquid chromatography with solid-phase extraction. J Agric Food Chem 53, 9885-9889.
21. Henning SM, Niu Y, Liu Y, Lee NH, Hara Y, Thames GD, Minutti RR, Carpenter CL, Wang H & Heber D (2005) Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J Nutr Biochem 16 610-616.
22. Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, Lambert G, Mohr S & Yang CS (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11, 1025-1032.
23. Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS & Hara Y (2001) Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 10, 53-58.
24. Lee MJ, Wang ZY, Li H, Chen L, Sun Y, Gobbo S, Balentine D & Yang CS (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 4, 393-399.
25. Van Amelsvoort JMM, Hof KHV, Mathot JNJJ, Mulder TPJ, Wiersma A & Tijburg LBM (2001) Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica 31, 891-901.
26. Yang CS, Chen L, Lee MJ, Balentine D, Chen Kuo M & Schantz SP (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 7, 351-354.
27. Mata ML, Lacueva CA, Roura E, Jáuregui O, Escribano, E, Torre C & Lamuela-Raventós RM (2007) Absorption and pharmacokinetics of grapefruit flavanones in beagles. Br J Nutr 98, 86-92.
28. Swezey RR, Aldridge DE, LeValley SE, Crowell JA, Hara Y & Green CE (2003) Absorption, tissue distribution and elimination of 4-[H-3]-epigallocatechin gallate in beagle dogs. Int J Toxicol 22, 187-193.
29. Committee on Care and Use of Laboratory Animals (1985) Guide for the Care and Use of Laboratory Animals. Washington, DC: Institute of Laboratory Animals Resources, National Research Council.
30. Roura E, Andres-Lacueva C, Jauregui O, Badia E, Estruch R, Izquierdo-Pulido M & Lamuela-Raventos RM (2005) Rapid liquid chromatography tandem mass spectrometry assay to quantify plasma (-)-epicatechin metabolites after ingestion of a standard portion of cocoa beverage in humans. J Agric Food Chem 53, 6190-6194.
31. Urpí-Sardà M, Jáuregui O, Lamuela-Raventós RM, Jaeger W, Miksits M, Covas MI & Andrés-Lacueva C (2005) Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal Chem 77, 3149-3155.
32. Meng X, Sang S, Zhu N, Lu H, Sheng S, Lee MJ, Ho CT & Yang CS (2002) Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem Res Toxicol 15, 1042-1050.
33. Unno T, Kondo K, Itakura H & Takeo T (1996) Analysis of (-)-epigaflocatecttin gallate in human serum obtained after ingesting green tea. Biosci Biotechnol Biochem 60, 2066-2068.
34. Kimura M, Umegaki K, Kasuya Y, Sugisawa A & Higuchi M (2002) The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr 56, 1186-1193.
35. Van het Hof KH, Kivits GA, Weststrate JA & Tijburg LB (1998) Bioavailability of catechins from tea: The effect of milk. Eur J Clin Nutr 52, 356-359.
36. Pietta PG, Simonetti P, Gardana C, Brusamolino A & Bombardelli E (1998) Catechin metabolites after intake of green tea infusions. Biofactors 8, 111-118.
37. Crespy V, Nancoz N, Oliveira M, Hau J, Courtet-compondu MC & Williamson G (2004) Glucuronidation of the green tea catechins, (-)-epigallocatechin-3-gailate and (-)-epicatechin-3-gallate, by rat hepatic and intestinal microsomes. Free Radic Res 38, 1025-1031.
38. Feng WY (2006) Metabolism of green tea catechins: An overview. Curr Drug Metab 7, 755-809.
39. Morand C, Crespy V, Manach C, Besson C, Demigné C & Rémésy C (1998) Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 275, 212-219.
40. Koga T & Meydani M (2001) Effect of plasma metabolites of (+ -catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr 73, 941-948.
41. Van Zanden JJ, Van der Woude H, Vaessen J, Usta M, Wortelboer HM, Cnubben N & Rietjens 1 (2007) The effect of quercetin phase R metabolism on its MRP1 and MRP2 inhibiting potential. Biochem Pharmacol 74 345-351.
42. Henning SM, Niu Y, Lee NH, Thames GD, Minutti RR, Wang H, Go VL & Heber D (2004) Bioavailability and antioxidal activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr 80 1558-1564.
43. Shargel L & Yu A (1999) Applied Biopharmaceutics and Phamacokinetics 4th ed. New York: Lange.
44. Chen L, Lee MJ, Li H & Yang CS (1997) Absorption, distribution, and elimination of the tea polyphenols in rats. Drug Metab Dispos 25, 1045-1050.